Answers are grounded in this paper and cite their sources.
Metoclopramide and domperidone are prokinetic agents commonly used to treat gastrointestinal dysmotility disorders. This study aimed to evaluate the safety and associated side effects of prolonged-use metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis (SSc).
No takes yet. Share an insight, caveat, or question.
Alkhowaiter et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: